Results 221 to 230 of about 26,274,125 (295)

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Early-Stage Breast Cancer: The BrIMA Nonrandomized Clinical Trial.

JAMA Surg
Göker M, Hahn M, Kraemer XE, Harrach H, Vanhoeij M, Vergauwen G, Van de Vijver K, De Man K, Schmidt F, Guergan S, Vergucht V, Di Micco R, Cisternino G, Gentilini OD.   +13 more
europepmc   +1 more source

Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study. [PDF]

J Cancer Res Clin Oncol
Li S, Xian B, Cui L, Wu L, Fang C, Yang F, Li J.   +6 more
europepmc   +1 more source

A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor-Associated Immune Cell Infiltration Abundance. [PDF]

Cancer Med
Zhang Y, Song S, Yu X, Li J.
europepmc   +1 more source

Assessing Lymph Node Metastasis Risk in Patients With Mucosal Gastric Cancer: A Comparison of the WHO and Japanese Criteria and Implications for Endoscopic Submucosal Dissection. [PDF]

JGH Open
Kim JC, Cho YS, Kwak Y, Kong SH, Park DJ, Cho SJ, Lee HJ, Lee HS, Yang HK.   +8 more
europepmc   +1 more source

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
, Kimberly Miller, Nikita Sandeep Wagle
exaly   +2 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
, Ahmedin Jemal, Mathieu Laversanne
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Galectin-3 in cancer

Clinica Chimica Acta, 2014
Galectin-3 (Gal-3) plays important roles in cell proliferation, adhesion, differentiation, angiogenesis and apoptosis in normal and pathologic tissues. Accumulated evidences indicate that Gal-3 is closely involved in tumor cell transformation, migration, invasion and metastasis. In this review, the associations of the expression and localization of Gal-
Lin, Song, Jian-wu, Tang, Lawrence, Owusu, Ming-Zhong, Sun, Jun, Wu, Jun, Zhang   +5 more
openaire   +2 more sources

Ovarian Cancer 3

Springer US, 1995
F. Sharp, P. Mason, T. Blackett, J. Berek   +3 more
openaire   +2 more sources

Galectin-3 and cancer (Review).

International Journal of Oncology, 2004
Galectin-3 is a pleiotropic carbohydrate-binding protein involved in a variety of normal and pathological biological processes. Its carbohydrate-binding properties constitute the basis for cell-cell and cell-matrix interactions and cancer progression. Modulation of galectin-3 expression in cancer cells has indeed been reported.
Califice, Stéphane, Castronovo, Vincenzo, van den Brûle, Fréderic   +2 more
openaire   +3 more sources

Breast Cancer 3.

Annals of Internal Medicine, 1980
J. Harris, M. Lippman, U. Veronesi, W. Willett   +3 more
openaire   +2 more sources